Evidence map›Paper›PMID 27805901›Full record

ArticleeLife2016

RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity.

Alison C McKelvey, Travis B Lear, Sarah R Dunn, John Evankovich, James D Londino, Joseph S Bednash, Yingze Zhang, Bryan J McVerry, Yuan Liu, Bill B Chen

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Role of Toll-Like Receptors 2 and 4 in the Pathogenesis of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2020
    Review
  13. Article
  14. Article
  15. The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis.Translational research : the journal of laboratory and clinical medicine · 2018
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Alison C McKelveyDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
Travis B LearDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.ORCID 0000-0001-9156-0844
Sarah R DunnDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
John EvankovichDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
James D LondinoDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
Joseph S BednashDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
Yingze ZhangDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
Bryan J McVerryDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.ORCID 0000-0002-1175-4874
Yuan LiuDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.
Bill B ChenDepartment of Medicine, University of Pittsburgh, Pittsburgh, United States.ORCID 0000-0003-2695-5107
University of Pittsburgh · US

Funding

Regulation of Cardiolin Byosynthesis in Epithelial InjuryP01HL114453 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2014 to 2023
$21.3M
Translational Training Program in Pulmonary Biology and MedicineT32HL007563 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Melanie Koenigshoff · 1985 to 2026
$12.3M
Regulation of Innate Immunity by F-Box ProteinsR01HL116472 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, BEIBEI · 2013 to 2017
$1.9M
HECT-domain E3 Ligase and Acute Lung InjuryR01HL132862 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, BEIBEI · 2016 to 2017
$976k
NHLBI NIH HHS P01 HL114453NHLBI NIH HHS R01 HL116472NHLBI NIH HHS R01 HL132862NHLBI NIH HHS T32 HL007563
6 · The paper itself

Abstract

Toll-like receptor 2 (TLR2) is a pattern recognition receptor that recognizes many types of PAMPs that originate from gram-positive bacteria. Here we describe a novel mechanism regulating TLR2 protein expression and subsequent cytokine release through the ubiquitination and degradation of the receptor in response to ligand stimulation. We show a new mechanism in which an uncharacterized RING finger E3 ligase, PPP1R11, directly ubiquitinates TLR2 both in vitro and in vivo, which leads to TLR2 degradation and disruption of the signaling cascade. Lentiviral gene transfer or knockdown of PPP1R11 in mouse lungs significantly affects lung inflammation and the clearance of

Indexed as

AnimalsHumansImmunity, InnateInflammationIntracellular Signaling Peptides and ProteinsLeukocytesLungMiceProteolysisStaphylococcal InfectionsStaphylococcus aureusToll-Like Receptor 2Ubiquitin-Protein LigasesIntracellular Signaling Peptides and ProteinsPPP1R11 protein, humanTLR2 protein, humanToll-Like Receptor 2Ubiquitin-Protein LigasesARDSbiochemistryE3 ligasehumanimmunologyinnate immunitymouseTLR2ubiquitinationvirus

Identifiers

PMID27805901
PMCPMC5092053
OpenAlexW2546472484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.